Connecticut Oncology Association

Patient Engagement and Digital Therapeutics – Scaling patient touch outside the practice walls, improving outcomes and practice scalability

  • 07 Sep 2022
  • 6:00 PM - 8:30 PM
  • Sheraton Hartford South, 100 Capital Blvd, Rocky Hill, CT


  • Charter Oak Corporate Members may reguster up to two attendees for free - Others must register as Corporate Event Paid Members or Guests
  • Corporate Nutmeg Members are allowed 1 free attendee, other attendees after that should register as Corporate Event Paid Member or Guest
  • For certain webinars, there will be no charge for additional corporate registrations, subject to capacity limitations

Registration is closed

Greetings,  Please join us and Bob Gold for the CT Oncology Association on Wed. Sept. 7, 2022 in person 


Meeting Date: Wed. Sept. 7, 2022     Time: Evening Meeting 6 pm to 8:30 pm

Location: Sheraton Hartford South (formerly Rocky Hill Marriott) Rocky Hill

6 pm registration, 6:20 buffet dinner, 6:40 meeting starts

Topic  Patient Engagement and Digital Therapeutics – Scaling patient touch outside the practice walls, improving outcomes and practice scalability

a particularly important topic for physicians, administrators, and patient care and support teams in every cancer center -  Patient engagement that successfully improves clinical outcomes, compliance and adherence, patient management, while connecting with the patient on their own terms, in their homes, between clinical visits…..  Patient engagement that can extend the value of the medical care without over-extending the resources of the medical team. These are practice enhancements required under the new CMS Enhancing Oncology Model, but not part of traditional practice models today.

 Bob Gold

Chief Clinical Behavioral Technologist and Founder

GoMo Health

“Patient Engagement and Digital Therapeutics – Scaling patient touch outside the practice walls, improving outcomes and practice scalability”

Bob Gold is one of the world’s leading behavioral technologists with more than 20 years applied research and development in the behavioral and cognitive science of human motivation, activation and resiliency; with a specialty in the design of clinical care plans and digital therapeutics that integrate pyscho-social factors and personal determinants into physical and behavioral care plans for chronic and complex population health management; with a focus in diversity, equity, and inclusion for underserved vulnerable populations.

Bob focuses his energy on recrafting clinical care plans and medication therapies into behaviorally-based remote care coordination, transitions of care, and rehabilitation/recovery digital therapy programs to achieve a sustainable population health business model for health systems, health plans, pharmaceutical companies and governments; reducing adverse events such as unnecessary ED visits and readmissions, collecting valuable ePROs (electronic patient-reported outcomes) and taking advantage of opportunities for Medicaid and Medicare value-based and RPM (Remote Patient Monitoring) reimbursements associated with the implementation of these programs.

Bob’s evidence-based methods provide an individualized, disciplined and nurturing experience within the framework of a person’s lifestyle and typical day while improving satisfaction and adherence; especially for complex and chronic conditions that include co-morbidities and difficult to navigate patient health journeys.  

Bob’s BehavioralRx® and Concierge Care® system has also shown to bring back Joy in Practice for doctors and nurses enabling them to spend more time on high impact clinical work. 

Bring your physician colleagues and staff.  You may register on the CT Oncology Association website,, or by email to

We will also be discussing plans for the Connecticut Oncology Association projects and meetings in 2023, and look forward to participation from practice physicians, administration and nurses.  All are encouraged to attend.  We also extend a warm welcome to any Residents or Fellows who wish to join us.

Please join the Connecticut Oncology Association in thanking our 2022 Charter Oak Partners to Date for helping us to bring this education program to our members: Abbvie, Bristol Myers Squibb, Genentech, Johnson & Johnson, Merck, Regeneron, Sanofi Genzyme, and Takeda Millenium.  2023 Corporate Partnership Applications are Now Available

We would also like to thank our other 2022 Nutmeg level corporate partners: Aveo, Astellas, Eisai, Incyte, Novartis, Pfizer and Taiho Oncology.  We look forward to welcoming these partners and others in 2023.

Please Complete & email the Registration Information Below by Friday, Sept  2 at noon.

I will be attending the CtOA Sept. 7, 2022 meeting at 6 pm Yes____ No___

Please register at,  Or email to

It is important to provide contact phone and email information, in case of adverse weather or unexpected issues.

Name:  ____________                                                          Affiliation:______________________________

Contact Phone #:_______________                    Contact Email:                          ________________________     ______

Staff and Physicians for Connecticut Practices, Physicians and staff     No Charge

Corporate Affiliate Members no charge for this webinar, but may be subject to capacity limits       

Thanks, Dawn

Dawn Holcombe FACMPE MBA ACHE 

Executive Director, Connecticut Oncology Association

33 Woodmar Circle

cell/main 860-305-4510, (main)

Connecticut Oncology Association (CtOA)

c/o Dawn Holcombe

33 Woodmar Circle
South Windsor, CT  06074
(860) 305-4510

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software